1. World Health Organization. Global Health Observatory. Geneva: World Health Organization; 2019. who.int/gho/database/en/. Accessed June 21, 2019.
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: A Cancer Journal for Clinicians,2018
3. Bauer, Katrina R., Monica Brown, Rosemary D. Cress, Carol A. Parise, and Vincent Caggiano. "Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype: a population‐based study from the California cancer Registry." cancer 109, no. 9,1721–1728, (2007).
4. Sugita, Bruna, Mandeep Gill, Akanskha Mahajan, Anju Duttargi, Saurabh Kirolikar, Rodrigo Almeida, Kenny Regis et al. "Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women." Oncotarget 7, no. 48 (2016): 79274.
5. Cancer and radiation therapy: current advances and future directions;Baskar R;Int J Med Sci.,2012